• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceINTERGEL ADHESION PREVENTION SOLUTION
Generic NameBarrier, absorbable, adhesion
ApplicantLIFECORE BIOMEDICAL, INC.
3515 LYMAN BLVD.
CHASKA, MN 55318
PMA NumberP990015
Date Received03/08/1999
Decision Date11/16/2001
Withdrawal Date 12/11/2007
Product Code MCN 
Docket Number 01M-0523
Notice Date 11/21/2001
Advisory Committee Obstetrics/Gynecology
Expedited Review Granted? Yes
Combination ProductNo
Approval Order Statement  
APPROVAL FOR THE GYNECARE INTERGEL ADHESION PREVENTIION SOLUTION. THE DEVICE IS INDICATED FOR USE IN PATIENTS UNDERGOING OPEN, CONSERVATIVE GYNECOLOGIC SURGERY AS AN ADJUNCT TO GOOD SURGICAL TECHNIQUE TO REDUCE POST-SURGICAL ADHESIONS. GYNECARE INTERGEL ADHESION PREVENTION SOLUTION IS ALSO INTENDED TO REDUCE THE LIKELIHOOD OF DEVELOPING MODERATE OR SEVERE POSTOPERATIVE ADNEXAL ADHESIONS IN THESE PATIENTS.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Supplements:  S001 S002 
-
-